Background Patients with vasculitis induced by the hepatitis C virus (HCV) have reduced levels
of regulatory T cells (Tregs). Resolution of HCV infection correlates with cure of vasculitis …

Abstract Treatment of hepatitis C (HCV)–mixed cryoglobulinemia (MC) may target either the
viral trigger (HCV) or the downstream B-cell clonal expansion. Prospective cohort study of …

Objective To evaluate the long‐term efficacy of anti–hepatitis C virus (HCV) therapy in
patients with HCV‐associated mixed cryoglobulinemia (HCV‐MC) vasculitis and to assess the …

Objective To report the long‐term mortality in patients with Behçet's disease (BD). Methods A
cohort of 817 patients fulfilling the international criteria for BD from a single center in France …

Behçet's disease (BD) is a recurrent systemic inflammatory disorder of unknown origin
characterized by oral and genital mucous ulcer, uveitis, and skin lesions. Involvement of large …

During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Behçet’s disease, also known as the Silk Road Disease, is a rare systemic vasculitis disorder
of unknown etiology. Recurrent attacks of acute inflammation characterize Behçet’s disease…

Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet’s syndrome (BS). The aim of the current effort was to update the …

Complement receptor 2–negative (CR2/CD21 − ) B cells have been found enriched in patients
with autoimmune diseases and in common variable immunodeficiency (CVID) patients …

Objective Regulatory T cells (Tregs) prevent autoimmunity and control inflammation.
Consequently, any autoimmune or inflammatory disease reveals a Treg insufficiency. As low-dose …